 Home > Medical News > Medicines Company News > The first generic drug "Axitinib" is about to be approved for listing

The first generic drug "Axitinib" is about to be approved for listing

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

canasa drug

epclusa drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, the official website of the State Food and Drug Administration showed that Shandong New Era's application for axitinib generic drug listing in category 4 is in the “under review” stage and will soon be approved by the NMPA.

Axitinib is a kinase inhibitor that can inhibit tyrosine kinases associated with pathological angiogenesis, tumor growth and cancer progression, vascular endothelial growth factor receptors VEGFR-1, VEGFR-2 and VEGFR-3 at therapeutic doses

Axitinib was originally developed by Pfizer and its English product name is Inlyta.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.